Close Menu

coronary artery disease

NEW YORK (GenomeWeb News) – Medison will make available CardioDx's Corus CAD diagnostic test for obstructive coronary artery disease in Israel as part of an agreement announced today.

A prospective study by a group of several primary care clinics and funded by CardioDx has found that CardioDx's coronary artery disease rule-out test, Corus CAD, significantly affected physician decision making in the primary care setting, changing doctors' treatment strategy for

NEW YORK (GenomeWeb News) – Two studies appearing in the American Journal of Human Genetics today uncovered a handful of low-frequency variants, including novel variants in ANGPTL8, PNPLA5, and PCSK7, among others, that seem to contribute to cholesterol or lipid levels in the blood.

NEW YORK (GenomeWeb News) – Cardiovascular molecular diagnostics firm CardioDx, which plans to go public with an intended offering of up to $86.3 million, said that its revenues for the first

NEW YORK (GenomeWeb News) – Horizon Discovery said today it has received a share of a European Union Seventh Framework Programme grant totaling €5.75 million ($7.8 million) for work it will do on a project called "CV genes-at-target."

NEW YORK (GenomeWeb News) – A pair of studies published online yesterday in Nature Genetics is expanding — and starting to delve into — the list of genetic loci associated with blood lipid leve

Prevencio, a proteomic diagnostic company working with technology licensed from the University of Pittsburgh, is hoping to begin a multi-center validation study within the next year that will support an application for US Food and Drug Administration approval of its multiplex pro

Researchers from Duke University have developed a gene-expression signature that is associated with how patients with coronary artery disease respond to preventive aspirin therapy.

NEW YORK (GenomeWeb News) – CardioDx today said that its laboratory in Palo Alto, Calif., has been accredited by the College of American Pathologists.

NEW YORK (GenomeWeb News) – CardioDx today announced a deal with Core Diagnostics India for the marketing and sale of CardioDx's coronary artery disease test in India.

Pages

New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.

A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.

Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.

In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.